Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P17
Within normal range
vs 3Y Ago
-1.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -20.51% |
| Q3 2025 | -14.71% |
| Q2 2025 | 20.93% |
| Q1 2025 | -2.38% |
| Q4 2024 | -16.67% |
| Q3 2024 | -5.88% |
| Q2 2024 | -3.03% |
| Q1 2024 | 29.79% |
| Q4 2023 | -14.63% |
| Q3 2023 | -20.59% |
| Q2 2023 | -9.68% |
| Q1 2023 | -19.23% |
| Q4 2022 | 18.75% |
| Q3 2022 | 0.00% |
| Q2 2022 | -10.34% |
| Q1 2022 | -11.54% |
| Q4 2021 | 0.00% |
| Q3 2021 | -23.81% |
| Q2 2021 | -51.84% |
| Q1 2021 | 55.39% |
| Q4 2020 | -72.22% |
| Q3 2020 | 5.26% |
| Q2 2020 | -18.75% |
| Q1 2020 | 0.00% |